INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 99 filers reported holding INTERSECT ENT INC in Q2 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $48,716,000 | -1.0% | 1,739,204 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $49,202,000 | +1.5% | 1,801,606 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $48,468,000 | +63.2% | 1,781,889 | +2.5% | 0.00% | 0.0% |
| Q2 2021 | $29,702,000 | -16.5% | 1,737,935 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $35,572,000 | -6.7% | 1,703,656 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $38,140,000 | +43.5% | 1,665,434 | +2.2% | 0.00% | 0.0% |
| Q3 2020 | $26,579,000 | +19.0% | 1,629,605 | -1.2% | 0.00% | 0.0% |
| Q2 2020 | $22,337,000 | +15.3% | 1,649,690 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $19,369,000 | -52.1% | 1,634,455 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $40,437,000 | +47.2% | 1,623,966 | +0.5% | 0.00% | 0.0% |
| Q3 2019 | $27,473,000 | -23.5% | 1,615,168 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $35,909,000 | -26.3% | 1,577,734 | +4.1% | 0.00% | -50.0% |
| Q1 2019 | $48,722,000 | +18.4% | 1,515,445 | +3.8% | 0.00% | 0.0% |
| Q4 2018 | $41,148,000 | +3.9% | 1,460,220 | +6.0% | 0.00% | 0.0% |
| Q3 2018 | $39,591,000 | -20.3% | 1,377,070 | +3.8% | 0.00% | 0.0% |
| Q2 2018 | $49,697,000 | -2.9% | 1,327,010 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $51,192,000 | +24.8% | 1,302,585 | +2.9% | 0.00% | 0.0% |
| Q4 2017 | $41,023,000 | +8.2% | 1,266,121 | +4.0% | 0.00% | 0.0% |
| Q3 2017 | $37,911,000 | +19.0% | 1,217,038 | +6.8% | 0.00% | 0.0% |
| Q2 2017 | $31,853,000 | +73.9% | 1,139,623 | +6.7% | 0.00% | +100.0% |
| Q1 2017 | $18,314,000 | +52.2% | 1,067,873 | +7.4% | 0.00% | 0.0% |
| Q4 2016 | $12,030,000 | -17.5% | 994,258 | +8.1% | 0.00% | 0.0% |
| Q3 2016 | $14,574,000 | +32.8% | 920,053 | +8.4% | 0.00% | 0.0% |
| Q2 2016 | $10,975,000 | -29.4% | 848,804 | +3.7% | 0.00% | 0.0% |
| Q1 2016 | $15,555,000 | +4.4% | 818,699 | +23.6% | 0.00% | 0.0% |
| Q4 2015 | $14,901,000 | -49.0% | 662,244 | -47.0% | 0.00% | 0.0% |
| Q3 2015 | $29,220,000 | +95.1% | 1,248,732 | +138.7% | 0.00% | 0.0% |
| Q2 2015 | $14,980,000 | +186.0% | 523,236 | +158.1% | 0.00% | – |
| Q1 2015 | $5,237,000 | +65.3% | 202,741 | +18.7% | 0.00% | – |
| Q4 2014 | $3,168,000 | +684.2% | 170,817 | +554.3% | 0.00% | – |
| Q3 2014 | $404,000 | – | 26,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |